Tocilizumab improves survival in critically ill Covid patients: Study
New York, Oct 21 In a major breakthrough, researchers including one of Indian-origin have found that tocilizumab drug reduced mortality by 30 per cent among critically ill Covid-19 patients when administered within the first two days of ICU admission. For
